SRF辅因子协同变化对房颤心房肌重构的调控作用研究

基本信息
批准号:81260020
项目类别:地区科学基金项目
资助金额:49.00
负责人:曾祥君
学科分类:
依托单位:贵州中医药大学
批准年份:2012
结题年份:2016
起止时间:2013-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:杨凡,种朋贵,梁青龙,方彦鹏,余娜,冯怡
关键词:
ELK1房颤反分化重构SRF辅因子
结项摘要

The molecular mechanisms of AF are poorly understood. Two major changes of atrial cell was supposed involve in the intrinsically progressive nature of AF. The first was electrical remodeling,and the second was structural remodeling .Together, these mechanisms contribute to the maintenance of AF. Several lines of evidence indicate that these atrial myocytes after sustained AF resemble immature muscle cells. The phenotypic resemblance with foetal cardiomyocytes point towards the nature of dedifferentiation of fibrillating atria which render the cardiomyocytes able to survive stress conditions. The transcriptional factor SRF has been shown to play an important role in regulating cell differentiation and proliferation. ELK-1 and smad1,members of transcription cofactors of SRF,was founded significantly expression changement in atrial tissue of patients with chronic AF compared to that with sinus rhythm in our earlier study. It's reasonable to presume that the transcription cofactors of SRF participated in the molecular and structural remodeling by which AF is sustained. In order to further ascertain the correlation between the transcriptional cofactors of SRF and the pathogenesis of chronic AF,we intend to observe the gene expression profile of the transcriptional cofactors of SRF in fibrillating atria by genechip,realtime RT-PCR and Western Blot,and investigate the genes function by gene overexpression and siRNA silence technology.

房颤心房肌出现电重构和结构重构,是房颤恶性发展的根本原因,但其发生、调控机制尚不清楚。既往研究证实SRF辅因子间存在相互联系,与血清反应因子SRF形成转录复合物,在细胞分化增生调节中起着关键作用,而反分化、增生及纤维化表现是房颤心房肌结构重构的典型特征。前期研究工作中我们先后观察到慢性房颤心房肌SRF辅因子ELK-1、smad1存在表达改变,因此推测:SRF辅因子协同变化在房颤心房肌重构中可能起着重要的调控作用。本课题拟利用表达谱基因芯片、实时RT-PCR、Western Blot等技术进一步明确房颤心房肌中SRF辅因子的表达变化状态,在此基础上构建心房肌特异性表达慢病毒载体,针对房颤心房细胞和羊房颤动物模型,施以SRF辅因子过表达、RNA沉默等基因干预,探讨SRF辅因子变化在房颤心房肌重构中的调控和协同作用,从而进一步揭示房颤的发病机制,为房颤的药物和基因治疗奠定基础。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老

TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老

DOI:10.3969/j.issn.1001-1978.2022.02.019
发表时间:2022
2

黄曲霉毒素B1检测与脱毒方法最新研究进展

黄曲霉毒素B1检测与脱毒方法最新研究进展

DOI:10.3969/j.issn.1000-4440.2021.03.031
发表时间:2021
3

黑色素瘤缺乏因子2基因rs2276405和rs2793845单核苷酸多态性与1型糖尿病的关联研究

黑色素瘤缺乏因子2基因rs2276405和rs2793845单核苷酸多态性与1型糖尿病的关联研究

DOI:10.3760/cma.j.issn.1674-5809.2019.12.008
发表时间:2019
4

Synthesis of an oligomeric thickener for supercritical carbon dioxide and its properties

Synthesis of an oligomeric thickener for supercritical carbon dioxide and its properties

DOI:10.1016/j.molliq.2020.113090
发表时间:2020
5

Glycyrrhetinic Acid Protects Renal Tubular Cells against Oxidative Injury via Reciprocal Regulation of JNK-Connexin 43-Thioredoxin 1 Signaling

Glycyrrhetinic Acid Protects Renal Tubular Cells against Oxidative Injury via Reciprocal Regulation of JNK-Connexin 43-Thioredoxin 1 Signaling

DOI:doi: 10.3389/fphar.2021.619567
发表时间:2021

相似国自然基金

1

MMPs和ADAMs在心房颤动时心房肌间质重构中的作用

批准号:30370564
批准年份:2003
负责人:张薇
学科分类:H0204
资助金额:20.00
项目类别:面上项目
2

calpainⅠ在心房颤动心房结构重构中的作用

批准号:30470686
批准年份:2004
负责人:李为民
学科分类:H0204
资助金额:8.00
项目类别:面上项目
3

染色质重塑对房颤心房肌肥大基因转录调控影响的研究

批准号:81500258
批准年份:2015
负责人:郑柳颖
学科分类:H0204
资助金额:18.00
项目类别:青年科学基金项目
4

心房纤维化重构对房颤影响机制的仿真研究

批准号:81501557
批准年份:2015
负责人:詹何庆
学科分类:H2805
资助金额:18.00
项目类别:青年科学基金项目